These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 4948221)

  • 41. Drug resistance and multi-drug therapy in leprosy.
    Chatterjee BR
    Lepr India; 1982 Jul; 54(3):402-11. PubMed ID: 6757576
    [No Abstract]   [Full Text] [Related]  

  • 42. Clofazimine-resistant leprosy, a case report.
    Warndorff-van Diepen T
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):139-42. PubMed ID: 6749703
    [No Abstract]   [Full Text] [Related]  

  • 43. Dapsone resistance in patients attending Central Leprosy Teaching and Research Institute, Chengalpattu (South India).
    Bhatia VN; Balakrishnan S; Seshadri PS; Neelan PN; Roy RG
    Indian J Lepr; 1984; 56(3):587-94. PubMed ID: 6396340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Follow up study of thirty-six borderline cases of leprosy.
    Kundu S; Ghosh S
    Bull Calcutta Sch Trop Med; 1967 Jul; 15(3):103-4. PubMed ID: 5616299
    [No Abstract]   [Full Text] [Related]  

  • 45. [Advances in the chemotherapy of leprosy].
    Grosset J
    Med Trop (Mars); 1984; 44(1):17-22. PubMed ID: 6377002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
    You EY; Kang TJ; Kim SK; Lee SB; Chae GT
    J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [New trends in the treatment of leprosy].
    Koźmińska-Kubarska A
    Pol Tyg Lek; 1983 Nov; 38(46):1439-41. PubMed ID: 6374636
    [No Abstract]   [Full Text] [Related]  

  • 48. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
    Thomas A; Hari L; Nagarajan M; Prabhakar R
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The therapeutic effect of 4,4'-diacetyldiamino-diphenylsulfone (DADDS) in leprosy.
    Shepard CC; Tolentino JG; McRae DH
    Am J Trop Med Hyg; 1968 Mar; 17(2):192-201. PubMed ID: 4870563
    [No Abstract]   [Full Text] [Related]  

  • 50. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of leprosy by sulfones and delayed-action sulfonamides: comparison of therapeutic results in 100 cases].
    Privat Y; Faye I; Bellossi A
    Mars Med; 1968; 105(3):276-80. PubMed ID: 5754252
    [No Abstract]   [Full Text] [Related]  

  • 52. Secondary sulphone resistance in leprosy (Report of a case).
    Lal S; Jaganath C; Garg BR; Paneerselvam R
    Lepr India; 1980 Apr; 52(2):299-301. PubMed ID: 7005542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Duration of specific treatment in leprosy.
    Skinsnes OK
    Int J Lepr Other Mycobact Dis; 1970; 38(1):85-8. PubMed ID: 4922039
    [No Abstract]   [Full Text] [Related]  

  • 54. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
    Kaur I; Dogra S; Kumar B; Radotra BD
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical and paraclinical aspects of secondary drug resistance to 4-4' diaminodiphenylsulfone in a population of leprosy patients in Bamako, Republic of Mali].
    Baquillon G; Ferracci C; Diallo J; Saint-Andreé P; Pattyn SR
    Acta Leprol; 1981; 85():40-52. PubMed ID: 6805234
    [No Abstract]   [Full Text] [Related]  

  • 56. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.
    Dhople AM
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):183-8. PubMed ID: 6373626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lepra reaction. Its relation with fragmentation of Mycobacterium leprae under sulfone therapy.
    Saul A; Segura N
    Int J Lepr Other Mycobact Dis; 1966; 34(1):17-22. PubMed ID: 5327411
    [No Abstract]   [Full Text] [Related]  

  • 58. Rifampicin resistant leprosy: a review and a research proposal of a pilot study.
    Ji B
    Lepr Rev; 2002 Mar; 73(1):2-8. PubMed ID: 11969122
    [No Abstract]   [Full Text] [Related]  

  • 59. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy.
    Job CK; Jayakumar J; Aschhoff M; Mathan MM
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):44-50. PubMed ID: 8627112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progress in the chemotherapy of leprosy.
    Grosset JH
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.